Does Rallies show 13F holders for AVAH?

Yes. Rallies tracks hedge fund and 13F ownership data for AVAH, including fund names, share counts, latest tracked quarter, and position changes when available.

Is AVAH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AVAH. It does not provide personalized investment advice.

AVAH (Aveanna Healthcare Holdings Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Aveanna Healthcare Holdings Inc. Common Stock (AVAH) is a publicly traded Healthcare sector company. As of May 21, 2026, AVAH trades at $7.50 with a market cap of $1.68B and a P/E ratio of 6.83. AVAH moved +0.66% today. Year to date, AVAH is -6.57%; over the trailing twelve months it is +33.57%. Its 52-week range spans $3.67 to $10.32. Analyst consensus is buy with an average price target of $9.94. Rallies surfaces AVAH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns AVAH stock?

Hedge funds tracked by Rallies that own AVAH include King Street, Panagora Asset, and Mangrove Partners. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Aveanna Healthcare Holdings Inc. Common Stock.

AVAH Key Metrics

Key financial metrics for AVAH
Metric	Value
Price	$7.50
Market Cap	$1.68B
P/E Ratio	6.83
EPS	$1.11
Dividend Yield	0.00%
52-Week High	$10.32
52-Week Low	$3.67
Volume	1.14K
Avg Volume	0
Revenue (TTM)	$2.43B
Net Income	$225.03M
Gross Margin	33.31%

Top Hedge Funds Holding AVAH

King Street holds 1.29M shares of AVAH, changed -71.74% as of Sep 30, 2025.
Panagora Asset holds 638.08K shares of AVAH, changed +25.60% as of Mar 31, 2026.
Mangrove Partners holds 109.06K shares of AVAH, changed +290.77% as of Mar 31, 2026.

Latest AVAH News

Aveanna Raises 2026 Revenue Guidance to $2.56–2.58B, Targets $328M–332M EBITDA — May 15, 2026
Aveanna Healthcare Q1 EPS of $0.18 Beats by $0.05, Raises Guidance — May 14, 2026
Aveanna Q4 EBITDA Jumps 54% to $85M; Family First Deal Adds $120M — Mar 19, 2026
Aveanna Lifts 2025 Revenue to $2.425–2.445B and Adjusted EBITDA to $318–322M; 2026 Revenue Seen at $2.54–2.56B — Jan 14, 2026
Aveanna Healthcare CEO Offloads 29,357 Shares for $230,452, Cutting Stake by 1.21% — Jan 3, 2026

Recent AVAH Insider Trades

Shaner Jeff sold 173.22K (~$1.25M) on Feb 19, 2026.
Cunningham Patrick A. sold 18.44K (~$132.89K) on Feb 19, 2026.
Buckhalter Matthew sold 13.51K (~$97.40K) on Feb 19, 2026.

AVAH Analyst Consensus

9 analysts cover AVAH: 0 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.94.

Common questions about AVAH

Who owns AVAH stock?: Hedge funds tracked by Rallies that own AVAH include King Street, Panagora Asset, and Mangrove Partners. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Aveanna Healthcare Holdings Inc. Common Stock.
Does Rallies show 13F holders for AVAH?: Yes. Rallies tracks hedge fund and 13F ownership data for AVAH, including fund names, share counts, latest tracked quarter, and position changes when available.
Is AVAH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AVAH. It does not provide personalized investment advice.